bevacizumab-irdye800cw
Showing 1 - 12 of 12
Thyroid Carcinoma, Surgery Trial in Groningen (Bevacizumab-IRDye800CW)
Enrolling by invitation
- Thyroid Carcinoma
- Surgery
- Bevacizumab-IRDye800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 18, 2023
Age-Related Macular Degeneration Trial (Bevacizumab-IRDye800CW, Vedolizumab-IRDye800CW)
Not yet recruiting
- Age-Related Macular Degeneration
- Bevacizumab-IRDye800CW
- Vedolizumab-IRDye800CW
- (no location specified)
May 19, 2022
Breast Cancer Trial (Bevacizumab-IRDye800CW)
Withdrawn
- Breast Cancer
- Bevacizumab-IRDye800CW
- (no location specified)
Apr 28, 2022
Esophageal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence Endoscopy platform)
Recruiting
- Esophageal Cancer
- Bevacizumab-IRDye800CW
- Molecular Fluorescence Endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 19, 2022
Pituitary Tumor, Pituitary Adenoma, Pituitary Macroadenoma Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence
Recruiting
- Pituitary Tumor
- +2 more
- Bevacizumab-IRDye800CW
- Molecular Fluorescence Endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
Aug 31, 2021
Hilar Cholangiocarcinoma Trial in Groningen (Bevacizumab-IRDye800CW, near infrared (NIR) fluorescence imaging)
Recruiting
- Hilar Cholangiocarcinoma
- Bevacizumab-IRDye800CW
- near infrared (NIR) fluorescence imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 27, 2021
Barrett Esophagus Trial in Groningen (Bevacizumab-IRDye800CW, Fluorescence endoscopy)
Recruiting
- Barrett Esophagus
- Bevacizumab-IRDye800CW
- Fluorescence endoscopy
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 3, 2020
Soft Tissue Sarcoma Trial in Groningen (Bevacizumab-IRDye800CW)
Completed
- Soft Tissue Sarcoma
- Bevacizumab-IRDye800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jan 27, 2020
Rectal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, NIR fluorescence endoscopy)
Completed
- Rectal Cancer
- Bevacizumab-IRDye800CW
- NIR fluorescence endoscopy
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Nov 23, 2017
Breast Cancer Trial in Groningen (bevacizumab-IRDye800CW)
Completed
- Breast Cancer
- bevacizumab-IRDye800CW
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 25, 2017
Esophageal Cancer, Dysplasia Trial in Groningen (Bevacizumab-IRDye800CW, Near infrared fluorescence endoscopy platform)
Completed
- Esophageal Cancer
- Dysplasia
- Bevacizumab-IRDye800CW
- Near infrared fluorescence endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 23, 2016
Adenomatous Polyposis Coli Trial in Groningen (Bevacizumab-IRDye800CW, Near infrared fluorescence endoscopy platform)
Completed
- Adenomatous Polyposis Coli
- Bevacizumab-IRDye800CW
- Near infrared fluorescence endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jan 8, 2016